Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco blog main
4
×
biotech
san francisco top stories
boston blog main
boston top stories
cancer
deals
national top stories
new york blog main
san diego blog main
san francisco
startups
10x genomics
alphabet
astellas pharma
becton dickinson
broad institute of harvard and mit
brook byers
california life sciences association (clsa)
cancer diagnostics
charles chu
clinical trials
community oncology alliance
crispr
crispr cas14
cvs health
decheng capital
diagnostic
diagnostic device
dna sequencing
drew pardoll
electronic health records
flatiron health
general atlantic
google
idiopathic pulmonary fibrosis (ipf)
infectious disease
investing
What
diagnostics
4
×
community
medicines
new
adding
aim
aims
available
based
better
big
bio
biosciences
boost
california
cancer
cas
change
cheaper
clinicians
companies
company
crispr
deal
decisions
develop
devices
diagnostic
disease
docs
education
established
expand
expects
faster
fight
flatiron
fold
fueled
giving
Language
unset
Current search:
diagnostics
×
" san francisco blog main "
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
5 years ago
California Life Sciences Fueled by Education, Established Companies
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care